SCHEMBL8831953

SCHEMBL8831953

Cn1c2ccccc2c2nc3ccc(C=O)cc3nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ HCRTR1 O43613 4/20 0.55
▸ L3MBTL1 Q9Y468 4/20 0.54
▸ LMNA P02545 2/20 0.54
▸ NR1I2 O75469 1/20 0.52
▸ AHR P35869 1/20 0.52
▸ MAPT P10636 7/20 0.51
▸ KDM4E B2RXH2 6/20 0.51
▸ CASP1 P29466 4/20 0.51
▸ CASP7 P55210 4/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ TSHR P16473 4/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ USP2 O75604 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832521 1.00 MEN1 (0.55) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8832020 0.87 MEN1 (0.54) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8832460 0.87 MEN1 (0.65) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL16621922 0.82 MEN1 (0.68) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8831999 0.80 L3MBTL1 (0.50) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8832096 0.78 L3MBTL1 (0.48) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8832725 0.75 LMNA (0.54) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8831950 0.75 LMNA (0.54) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL8832235 0.73 MEN1 (0.47) MEN1KMT2AHCRTR1L3MBTL1LMNA
SCHEMBL29570020 0.72 PTGER4 (0.64) MEN1KMT2AL3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 — — US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 — — EP disclosed
Send feedback